Home About Us Contact Us
CMEweb.com
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
Your Payment History
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
Accreditation
State Requirements
FAQs
 
Home : Advanced Search : Course view






This course is no longer active as of 2019-09-30

OB/GYN Clinical Alert (Vol. 33, No. 5) – September 2016


Specialty: OB/GYN Format: Text 
Course #: 13860  Price: $40.50  
Release date: 2016-08-16  Valid through: 2019-09-30  
Publication: This activity appeared in OB/GYN Clinical Alert, published on 2016-09-01. 
Course viewing requirements  (opens in a new window)
Instructions for Course Participation  (opens in a new window)
Legal disclaimer  (opens in a new window)


Release date: September 2016

Valid through: September 2019

Target Audience

This activity is intended for the obstetrician and gynecologist and nurses in OB/GYN practices.

Subjects

  • Is an Even Safer Combined Oral Contraceptive Pill Available?
  • Genetic Testing: Who Should Be Tested and What Should They Be Tested For?
  • Oligohydramnios: How to Best Diagnose It and What It Really Means
  • PCOS and Hormonal Contraception: A Tale of Two Syndromes?

Objectives

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Rebecca Allen, MD, Assistant Professor, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women and Infants’ Hospital, Providence, RI

Molly A. Brewer, DVM, MD, MS, Professor and Chair, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Connecticut Health Center, Farmington

John C. Hobbins, MD, Professor, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora

Jeffrey T. Jensen, MD, MPH, Leon Speroff Professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland

Editors

Medical Editor: Jeffrey T. Jensen, MD, MPH

Peer Reviewer: Catherine Leclair, MD

Nurse Planner: Marci Messerle Forbes, RN, FNP

Nurse Planner: Andrea O’Donnell, RN, FNP

AHC Media Executive Editor: Leslie G. Coplin

Associate Managing Editor: Jonathan Springston

Financial Disclosure

Jeffrey T. Jensen, MD, MPH reports he is a consultant for Teva Pharmaceuticals, MicroChips, and Evofem; and is a consultant for and receives grant research support from Bayer Healthcare, Merck, Agile Pharm, Population Council, AbbVie, ContraMed, and FHI360; and receives grant/research support from HRA Pharma and Medicines 360. Rebecca Allen, MD reports she is a Nexplanon trainer for Merck, and she has served on advisory boards for Bayer and Pharmanest. Molly A. Brewer, MD reports she receives grant/research support from the National Cancer Institute. John C. Hobbins, MD reports no financial relationships relevant to this field of study.

OB/GYN Clinical Alert's Editor, Jeffrey T. Jensen, MD, MPH, reports he is a consultant for Teva Pharmaceuticals, MicroChips, and Evofem; and is a consultant for and receives grant research support from Bayer Healthcare, Merck, Agile Pharm, Population Council, AbbVie, ContraMed, and FHI360; and receives grant/research support from HRA Pharma and Medicines 360.

Peer Reviewer Catherine Leclair, MD, Nurse Planners Marci Messerle Forbes, RN, FNP, and Andrea O’Donnell, RN, FNP, Executive Editor Leslie G. Coplin, and Associate Managing Editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.

This course is no longer available to take.

 


For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com.